Invention Grant
- Patent Title: Use of N-acetylglucosamine and derivatives thereof to treat muscle disorders
-
Application No.: US16045250Application Date: 2018-07-25
-
Publication No.: US10912787B2Publication Date: 2021-02-09
- Inventor: Sachiko Sato , Masahiko Sato , Ann Rancourt
- Applicant: PUREPHARM INC.
- Applicant Address: CA Toronto
- Assignee: PUREPHARM INC.
- Current Assignee: PUREPHARM INC.
- Current Assignee Address: CA Toronto
- Agency: Howson & Howson LLP
- Agent Colleen M. Schaller
- Priority: CA2968160 20170526
- Main IPC: A61K31/7008
- IPC: A61K31/7008 ; A61P21/00
Abstract:
Methods of preventing or delaying the weakening of as well as improving the strengthening of muscles includes the step of providing an effective amount or dose of N-acetylglucosamine (GlcNAc), related saccharides, or combinations thereof both to improve myogenesis.
Public/Granted literature
- US20180369261A1 USE OF N-ACETYLGLUCOSAMINE AND DERIVATIVES THEREOF TO TREAT MUSCLE DISORDERS Public/Granted day:2018-12-27
Information query
